Dib Ultranav Transseptal Catheter System
Dib Ultranav Medical
FDA Clearance Information
The Dib Ultranav Transseptal Catheter System was cleared through the FDA 510k pathway on March 24, 2022. Manufactured by Dib Ultranav Medical, it is classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Provides transseptal access to the left atrium during cardiac catheter-based procedures.
Clinical Applications
- Establishing a catheter pathway from the right atrium to the left atrium.
- Supporting catheter-based procedures that require left atrial access.
- Providing access through the interatrial septum under appropriate imaging guidance.
Practical Considerations
- The system generally includes a transseptal sheath and dilator; available sizes and configurations should be confirmed in the current device labeling.
- Use requires clinicians trained in transseptal puncture and management of potential complications such as cardiac perforation, pericardial effusion, bleeding, air embolism and vascular injury.
- Transseptal access is typically performed in a cardiac catheterization or electrophysiology laboratory using fluoroscopy, often with echocardiographic guidance.
- MRI safety and conditions should be verified in the current manufacturer labeling; this record does not establish that the system is MR Safe or MR Conditional.
- Patient-specific contraindications, anticoagulation management, septal anatomy and the need for alternative access should be assessed before use.
Frequently Asked Questions
What is the Dib Ultranav Transseptal Catheter System used for?
It is used for transseptal access to the left atrium during cardiac procedures such as atrial fibrillation ablation.
What specialties typically use this device?
Cardiologists and electrophysiologists typically use this device in catheterization labs.
What are the FDA-cleared indications?
The device is indicated for procedures requiring transseptal access to the left atrium, such as atrial fibrillation ablation.